BA
The Boeing Company
BA's outlook is improving, though it still trails on the overall score.
CRS
Carpenter Technology Corporation
CRS has the edge over BA overall, supported by stronger valuation and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CRS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Healthy |
CRS's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CRS in the historical PE scenario, which offers more potential upside but is not a forecast.
CRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $222 | -26% |
| Forward | 22x | $300 | — |
| Current | 26x | $300 | — |
| Fair | 38x | $427 | +43% |
| Expensive | 50x | $572 | +91% |
Historical ranges are pointers, not guarantees.
CRS's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CRS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CRS, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.93 | +23% |
| Q3 2026 | $11.34 | +39% |
| Q2 2026 | $10.52 | +42% |
| Q1 2026 | $9.50 | +35% |
| Q4 2025 | $8.61 | +62% |
| Q3 2025 | $8.18 | +82% |
| Q2 2025 | $7.42 | +101% |
| Q1 2025 | $7.06 | +169% |
| Q4 2024 | $5.30 | +84% |
CRS has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CRS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $798.2M | +8.8% |
| Q2 2026 | $851M | +13% |
| Q1 2026 | $811.5M | +12% |
| Q4 2025 | $728M | +7.5% |
| Q3 2025 | $733.7M | +2.2% |
| Q2 2025 | $755.6M | -5.4% |
| Q1 2025 | $727M | +6.1% |
| Q4 2024 | $676.9M | +8.4% |
CRS's revenue is recovering but still below its 2023 peak: $798M last quarter, up 8.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +3.7 points |
| Q2 2026 | 24% | +4.3 points |
| Q1 2026 | 23% | +4 points |
| Q4 2025 | 21% | +3.8 points |
| Q3 2025 | 21% | +5.1 points |
| Q2 2025 | 20% | +6.5 points |
| Q1 2025 | 19% | +7.9 points |
| Q4 2024 | 18% | +6.4 points |
CRS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CRS on cash flow, with more consistent year-over-year improvement.
CRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$24.9M | -$21.5M |
| Q2 2026 | $155M | -23% |
| Q1 2026 | $124.8M | +267% |
| Q4 2025 | $85.9M | +123% |
| Q3 2025 | -$3.4M | -126% |
| Q2 2025 | $200.1M | +41% |
| Q1 2025 | $34M | -45% |
| Q4 2024 | $38.6M | +$49.4M |
CRS usually generates cash, though not every quarter: the latest was −$25M, but it generated $341M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -200K shares |
| 1 year | -0.8% | -400K shares |
| 3 years | +0.2% | +100K shares |
| 5 years | +3.1% | +1.5M shares |
| Available history | +3.1% | +1.5M shares |
CRS has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $133.9M |
| Q2 2026 | $45.2M |
| Q1 2026 | $52.7M |
| Q4 2025 | $32.1M |
| Q3 2025 | $49.1M |
| Q2 2025 | $24.1M |
| Q1 2025 | $37.5M |
| Q4 2024 | $8.2M |
CRS spent $264M buying back its own shares over the past year, up 122% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 1.0x | Very low |
CRS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 4.9 | Oversold |
CRS's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CRS on valuation relative to its sector.
CRS PE vs Industrials Sector
| Metric | CRS | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 9.9% above |
| PE % | 22 | 58 | 36 pts below |
CRS is trading at 26x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.7 | 11% below |
| 20 week MA | $448.1 | 33% below |
| 50 week MA | $420.4 | 29% below |
| 100 week MA | $326.6 | 8.3% below |
| 200 week MA | $206.4 | 45% above |
CRS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.3 | $28.6 | -43% |
| 2021 | $28.6 | $29.0 | +1.2% |
| 2022 | $29.0 | $37.8 | +30% |
| 2023 | $37.8 | $70.8 | +87% |
| 2024 | $70.8 | $170.7 | +141% |
| 2025 | $170.7 | $334.4 | +96% |
| 2026 YTD | $334.4 | $299.6 | -10% |
CRS has the edge over BA on returns for 2026, with the stronger performance.